Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Canada
/
Pharmaceuticals & Biotech
/
Aurora Cannabis
ACB
Aurora Cannabis
Global Cannabis Legalization And Medical Integration Will Expand Wellness Markets
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
22 Aug 25
Updated
22 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
CA$10.00
30.8% undervalued
intrinsic discount
22 Aug
CA$6.92
Loading
1Y
-21.5%
7D
-1.1%
Author's Valuation
CA$10.0
30.8% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
CA$10.0
30.8% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-3b
422m
2015
2017
2019
2021
2023
2025
2027
2028
Revenue CA$421.8m
Earnings CA$95.7m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
5.99%
Pharma revenue growth rate
0.58%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
5.97%
Calculation
CA$95.70m
Earnings '28
x
7.58x
PE Ratio '28
=
CA$725.86m
Market Cap '28
CA$725.86m
Market Cap '28
/
61.46m
No. shares '28
=
CA$11.81
Share Price '28
CA$11.81
Share Price '28
Discounted to 2025 @ 5.97% p.a.
=
CA$9.92
Fair Value '25